Global Cluster Headache Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Type;

Episodic and Chronic.

By Drug Type;

Fast-Acting Drugs, Long-Term Drugs, and Short-Term Drugs.

By Route of Administration;

Oral, Topical, Intravenous, and Others.

By Distribution Channels;

Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn100701432 Published Date: March, 2024 Updated Date: April, 2024

Introduction

Global Cluster Headache Market (USD Million), 2020 - 2030

In the year 2023, the Global Cluster Headache Market was valued at USD 402.12 million. The size of this market is expected to increase to USD 620.79 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.4%.

Cluster headaches are the most common of the primary headache types known as trigeminal autonomic cephalgia. Like other trigeminal autonomic cephalgia's, these headaches can occur every other day to eight times a day. They usually occur at approximately the same time of day, most often at night. Most patients are episodic, with daily attacks for weeks to months, followed by remission for months to years. Cluster headache is a short-lasting unilateral headache with at least one autonomic symptom ipsilateral to the headache, such as lacrimation, nasal congestion, conjunctival injection, or aural fullness. The cluster headache is divided into two types depending upon the period of cluster headache: episodic and chronic.

Growth & innovations in the pharmaceutical industry for the manufacturing of cluster headache drugs owing to massive pool of health-conscious consumers, creates an opportunity for the cluster headache market. Rise in launch of various monoclonal antibodies for cluster headache, increase in number of clinical trials of new drugs by various key players across the globe are set to affect the market growth positively. In addition, various drugs are in clinical stages of approval for cluster headache which is projected to fuel the growth of the market. For instance, article published in U.S. National Library of Medicine – Clinical Trials, stated that, Psilocybin is in clinical phase 2 trial which can be used as preventative therapy for cluster headache. Thus, rise in number pipeline medications for cluster headache is anticipated to drive the growth of the market.

In addition, prevalence of cluster headache is increasing in pediatric population, thus driving the growth of the market. For instance, article published in Journal of Head and Face Pain, reported that, 27.5% of pediatric population were diagnosed with cluster headaches. Thus, rise in prevalence of cluster headache in pediatric population is expected to drive the growth of market. The growth of the cluster headache market is expected to be driven by emerging markets, due to availability of improved healthcare infrastructure, increase in unmet healthcare needs, rise in prevalence of cluster cases in adults, and surge in demand for steroidal drugs for management of cluster headache. Furthermore, the healthcare industry in emerging economies is developing at a significant rate, owing to rise in demand for enhanced healthcare services, significant investments by government to improve healthcare infrastructure, and development of the medical tourism industry in emerging countries.

Various organizations along with government are counselling people regarding the headache disorders. E-commerce (electronic commerce) has become a vital tool for small and large businesses globally, due to rise in preference of consumers for online shopping over traditional purchasing methods. Various animations through health apps to educate people regarding headache disorders and usage of medications have contributed toward the growth of cluster headache market. The demand for effective calcium channel blockers and steroids such as prednisone is not only limited to developed countries but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuel the growth of the market. Moreover, increase in promotional activities by manufacturers and growth in awareness for proper treatment medications for cluster headache among the general population is expected to fuel their adoption in the near future.

However, side effects of the drug used in cluster headache restrains the growth of the cluster headache market. In addition, absence of favorable reimbursement policies is expected to constrain the growth of the market. In contrast, rise in demand for novel therapies such as biologics, increase in awareness about treatment options and increase in R&D to develop safe and efficacious drugs for cluster headache treatment offer lucrative opportunities to key players of the cluster headache market.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Drug Type
    3. Market Snapshot, By Route of Administration
    4. Market Snapshot, By Distribution Channels
    5. Market Snapshot, By Region
  4. Global Cluster Headache Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Healthcare Expenditure

        2. Growing Patient Awareness and Education

        3. Technological Advancements in Treatment

      2. Restraints
        1. Limited Awareness

        2. High Cost of Treatment

        3. Side Effects of Medications

      3. Opportunities
        1. Personalized Medicine

        2. Telemedicine and Digital Health

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Cluster Headache Market, By Type, 2022 - 2032 (USD Million)
      1. Episodic
      2. Chronic
    2. Global Cluster Headache Market, By Drug Type, 2022 - 2032 (USD Million)
      1. Fast-Acting Drugs
      2. Long-Term Drugs
      3. Short-Term Drugs
    3. Global Cluster Headache Market, By Route of Administration, 2022 - 2032 (USD Million)

      1. Oral

      2. Topical

      3. Intravenous

      4. Others

    4. Global Cluster Headache Market, By Distribution Channels, 2022 - 2032 (USD Million)

      1. Hospital Pharmacies

      2. Retail Pharmacies

      3. Online Pharmacies

    5. Global Cluster Headache Market, By Geography, 2022 - 2032 (USD Million)
      1. North America

        1. United States

        2. Canada

      2. Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Nordic

        7. Benelux

        8. Rest of Europe

      3. Asia Pacific

        1. Japan

        2. China

        3. India

        4. Australia & New Zealand

        5. South Korea

        6. ASEAN (Association of South East Asian Countries)

        7. Rest of Asia Pacific

      4. Middle East & Africa

        1. GCC

        2. Israel

        3. South Africa

        4. Rest of Middle East & Africa

      5. Latin America

        1. Brazil

        2. Mexico

        3. Argentina

        4. Rest of Latin America

  6. Competitive Landscape
    1. Company Profiles
      1. Zosano Pharma

      2. Eli Lilly and Company

      3. Lundbeck Seattle BioPharmaceutical

      4. Winston Laboratories

      5. GlaxoSmithKline plc.

      6. ElectroCore Medical LLC

      7. Autonomic Technologies, Inc.

      8. AstraZeneca plc.

      9. Allergan plc.

      10. Bayer AG

      11. F. Hoffmann-La Roche Ltd

      12. Novartis AG

      13. Sun Pharmaceutical Industries Ltd

      14. Teva Pharmaceutical Industries Ltd.

      15. Takeda Pharmaceutical Company Limited

  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Medical Devices CO2 Incubator
Global CO2 Incubator Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global CO2 Incubator Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Cold Laser Therapy
Global Cold Laser Therapy Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Cold Laser Therapy Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Cold Plasma In Healthcare
Global Cold Plasma In Healthcare Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Cold Plasma In Healthcare Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Collagen and HA-based Biomaterials
Global Collagen and HA-based Biomaterials Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Collagen and HA-based Biomaterials Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...